Al-Modawat Specialized Medical Co. (9594.SR)
SAR 15.84
(4.9%)
SAR 15.84
(4.9%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 74.3 Million | 58.56 Million | 40.83 Million |
| Cost of Revenue | 33.68 Million | 30.67 Million | 26.8 Million |
| Gross Profit | 40.62 Million | 27.88 Million | 14.03 Million |
| Operating Expenses | 20.46 Million | 16.44 Million | 14.92 Million |
| Selling, General and Administrative Expenses | 3.23 Million | 16.44 Million | 14.92 Million |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | - | - |
| Cost and Expenses | 50.95 Million | 47.12 Million | 41.73 Million |
| Operating Income | 23.35 Million | 11.44 Million | -893.74 Thousand |
| Interest Expense | 1.32 Million | 693.46 Thousand | 35.19 Thousand |
| Income Tax Expense | 853 Thousand | 296.44 Thousand | 1.51 Million |
| Earnings before Tax | 19.44 Million | 10.6 Million | -693.6 Thousand |
| Net Income | 18.59 Million | 10.31 Million | -2.2 Million |
| Earnings Per Share Basic | 0.98 | 0.43 | -0.09 |
| Earnings Per Share Diluted | 0.98 | 0.43 | -0.09 |
| Weighted Average Shares Outstanding | 19 Million | 23.75 Million | 23.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 19 Million | 23.75 Million | 23.75 Million |
| Gross Margin | 0.55 | 0.48 | 0.34 |
| EBIT Margin | 0.28 | 0.23 | 0.03 |
| Profit Margin | 0.25 | 0.18 | -0.05 |
| EBITDA | 20.76 Million | 13.4 Million | 1.26 Million |
| Earnings Before Tax Margin | 0.31 | 0.20 | -0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 18.64 Million | 18.64 Million | 74.3 Million | 18.56 Million | 18.56 Million | 37.17 Million |
| Cost of Revenue | 9.97 Million | 9.97 Million | 33.68 Million | 9.07 Million | 9.07 Million | 15.77 Million |
| Gross Profit | 8.66 Million | 8.66 Million | 40.62 Million | 9.48 Million | 9.48 Million | 21.4 Million |
| Operating Expenses | 6.77 Million | 6.77 Million | 19.79 Million | 3.56 Million | 5.14 Million | 9.88 Million |
| Selling, General and Administrative Expenses | 6.77 Million | 6.77 Million | - | 3.56 Million | 3.56 Million | 9.88 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | 1.00 | -2.00 | - | - |
| Cost and Expenses | 16.75 Million | 16.75 Million | 33.68 Million | 12.64 Million | 14.22 Million | 25.65 Million |
| Operating Income | 1.89 Million | 1.89 Million | 40.62 Million | 5.91 Million | 5.17 Million | 11.51 Million |
| Interest Expense | - | - | 1.32 Million | - | - | 564.62 Thousand |
| Income Tax Expense | 374.16 Thousand | 374.16 Thousand | 853 Thousand | 229.79 Thousand | 229.79 Thousand | 393.42 Thousand |
| Earnings before Tax | 1.96 Million | 1.96 Million | 19.44 Million | 4.06 Million | 4.06 Million | 11.32 Million |
| Net Income | 1.58 Million | 1.58 Million | 18.59 Million | 3.83 Million | 3.83 Million | 10.93 Million |
| Earnings Per Share Basic | 0.07 | 0.07 | - | 0.20 | 0.20 | 0.46 |
| Earnings Per Share Diluted | 0.07 | 0.07 | - | 0.20 | 0.20 | 0.46 |
| Weighted Average Shares Outstanding | 22.14 Million | 22.14 Million | 19 Million | 19 Million | 19 Million | 23.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.31 Million | 22.31 Million | 19 Million | 19 Million | 19 Million | 23.75 Million |
| Gross Margin | 0.46 | 0.46 | 0.55 | 0.51 | 0.51 | 0.58 |
| EBIT Margin | 0.13 | 0.13 | - | 0.30 | 0.30 | 0.36 |
| Profit Margin | 0.08 | 0.08 | 0.25 | 0.21 | 0.21 | 0.29 |
| EBITDA | 2.4 Million | 2.4 Million | - | 5.62 Million | 5.62 Million | 13.34 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | 0.55 | 0.32 | 0.28 | 0.31 |
WAY
ASTEC
SASKEN
PLASTIBLEN
FIPP
BETR